NIPT is remarkably accurate at identifying fetal sex, but it is not infallible. Across large reviews, the test correctly identifies sex with a sensitivity around 96–99% and specificity above 99%, which means a small but real number of results turn out to be wrong. The reasons range from biological quirks in the mother’s blood to rare medical scenarios that most people never think to mention to their provider. Understanding what can throw off the result helps explain why confirmatory ultrasound still matters and why a surprising NIPT sex call does not always mean there is something wrong with the pregnancy.
How Accurate NIPT Sex Determination Actually Is
A health technology assessment of NIPT for fetal sex determination found the test’s sensitivity to be about 99% and its specificity close to 99.6%, with correspondingly high predictive values in both directions.1Health Technology Assessment. Non-invasive prenatal testing (NIPT) for foetal sex determination A broader meta-analysis pooling over 10,000 tests across 90 studies reported an average sensitivity of about 97% and specificity around 99%. Performance improved with gestational age: at five weeks the numbers dipped to roughly 93% sensitivity and 95% specificity, while by 13 weeks sensitivity climbed to about 98% with specificity near 99%.2BioMed Central / BMC Research Notes. Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis Those numbers sound excellent, and they are. But when millions of tests are performed each year, even a 1–2% error rate translates into thousands of families getting an unexpected surprise at delivery or on a later ultrasound.
Fetal Fraction and Why It Matters
The single biggest factor behind inaccurate NIPT results is something called fetal fraction. When you are pregnant, fragments of DNA from the placenta circulate in your blood alongside your own cell-free DNA. The share belonging to the fetus is the fetal fraction, and it needs to be high enough for the lab to reliably distinguish fetal signals from the maternal background. Most laboratories set a minimum threshold around 4%. Below that, results become unreliable or the lab may report no result at all.3Europe PMC. Factors Affecting the Fetal Fraction in Noninvasive Prenatal Screening: A Review When fetal fraction is borderline, sex determination is especially vulnerable because the test is essentially looking for traces of Y-chromosome DNA. If there is very little fetal DNA in the sample, a male fetus can appear female simply because the Y signal gets lost in the noise.
Maternal Weight and Fetal Fraction
Higher maternal body weight is one of the most consistent predictors of a low fetal fraction. The relationship is straightforward: as BMI goes up, fetal fraction goes down. One large study found that the rate of fetal fraction falling below 4% was about 4.5% in normal-weight women but jumped to roughly 20% in women with a BMI over 30, and reached about 35% in women with severe obesity.4PubMed Central. Impact of Maternal Body Mass Index (BMI) on the Performance of Non-Invasive Prenatal Testing (NIPT) Another analysis controlling for other variables confirmed a clear negative correlation between increasing BMI and fetal fraction.5PubMed Central. Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA
The reason is not that larger women produce less placental DNA. Rather, they tend to have more total cell-free DNA circulating from their own tissues, which dilutes the fetal share. Research looking at cell-based NIPT confirmed the same pattern, with trophoblast cell yield showing an inverse relationship with BMI.6PubMed Central. The effect of maternal body mass index and gestational age on circulating trophoblast yield in cell-based noninvasive prenatal testing For women with a higher BMI, waiting a week or two longer before drawing blood can help, since fetal fraction generally rises as pregnancy progresses.
When You Test Makes a Difference
Most providers offer NIPT starting around 10 weeks of gestation, and there is good reason for that threshold. Earlier in pregnancy, fetal fraction is lower and the chance of an uninformative or inaccurate result climbs. One study found that fetal fraction does not rise in a smooth, linear way as the pregnancy advances. There is actually a temporary dip around 15 weeks before the fraction resumes climbing, a pattern the researchers called “non-intuitive.”7PubMed. Non-intuitive trends of fetal fraction development related to gestational age and fetal gender, and their practical implications for non-invasive prenatal testing This means that testing at certain points in mid-pregnancy could, somewhat counterintuitively, yield a weaker fetal signal than testing a couple of weeks earlier.
For sex determination specifically, Y-chromosome concentration increases with gestational age in a logarithmic pattern, but the gain is offset in women with higher BMI. Research modeling the interaction between gestational age and BMI suggests that controlling the testing window between about 11 and 19 weeks keeps the false-negative rate for male fetuses below 2% for most women.8Journal of Computing and Electronic Information Management. Timing of NIPT and Fetal Abnormality Determination In other words, testing too early, especially if you have a higher BMI, raises the odds of a male baby being called female.
On the other end, newer research is exploring whether enrichment techniques could push reliable testing earlier than 10 weeks. A study of over 400 women sampled between 7 and 10 weeks found that with in vitro fetal enrichment, sex determination was 100% concordant with sex at birth for both early and standard-timing samples, though about 6% of male pregnancies still had fetal fractions below 4% even after enrichment.9PubMed Central. Prenatal Cell-Free DNA Screening With Fetal Enrichment Enables Sampling From 8 Weeks of Gestational Age This technology is promising but not yet widely available.
The Vanishing Twin Problem
One of the more unsettling causes of a wrong NIPT sex result involves a pregnancy that started as twins but where one embryo stopped developing very early, often before the first ultrasound. This is called the vanishing twin phenomenon, and it happens more often than most people realize, particularly in pregnancies conceived through IVF. The problem is that the placental tissue from the demised twin can keep releasing DNA into the mother’s bloodstream for weeks or even months after the twin has stopped growing.
If the vanishing twin was male and the surviving baby is female, the leftover Y-chromosome DNA can lead NIPT to report a male result. The reverse can also happen: a demised twin with a chromosomal abnormality can generate a false-positive for that condition in the surviving baby.10PubMed Central. Discordant NIPT result in a viable trisomy-21 pregnancy due to prolonged contribution to cfDNA by a demised trisomy-14 cotwin Research into the mechanism found that the demised twin’s necrotic placental tissue essentially floods the mother’s blood with cell-free DNA in a burst, and that DNA does not clear quickly.11PubMed. False positive non-invasive prenatal testing results due to vanishing twins There is no reliable way for the lab to tell whether the DNA fragments it is reading come from one placenta or two, which makes this a particularly tricky source of error.
Maternal Mosaicism and Unexpected Chromosome Patterns
NIPT does not actually sequence fetal DNA in isolation. It reads all cell-free DNA in the mother’s blood and then uses statistical methods to separate the fetal signal from the maternal background. This means that any unusual chromosome pattern in the mother’s own cells can contaminate the result. One common scenario involves maternal mosaicism for sex chromosomes, where some of the mother’s cells are missing an X chromosome (a condition related to Turner syndrome). The mother may have no idea she carries this mosaic pattern because it often produces no symptoms.
Studies investigating false-positive results for X-chromosome loss on NIPT have found maternal mosaicism to be surprisingly common among the explanations. In one cohort of women whose NIPT flagged chromosome X loss but whose fetuses turned out to be normal, about 37% of those who were tested showed mosaic or altered sex chromosome status in their own white blood cells.12PubMed. Contribution of maternal mosaicism to false-positive chromosome X loss associated with noninvasive prenatal testing A separate study reported that over half of women with false-positive monosomy X results from NIPT were found to carry maternal mosaic monosomy X.13PubMed. Relationships among maternal monosomy X mosaicism, maternal trisomy, and discordant sex chromosome aneuploidies When the lab sees fewer X-chromosome fragments than expected, it may interpret that as a Turner syndrome signal or incorrectly assign fetal sex, when the anomaly is actually coming from the mother.
Prior Transplants Can Fool the Test
This is a rare scenario, but it produces dramatic results. If you have ever received an organ transplant or a bone marrow/stem cell transplant from a donor of the opposite sex, that donor’s DNA circulates in your blood permanently. The NIPT lab has no built-in way to distinguish donor DNA from fetal DNA.
In one published case, a woman who had previously received a stem cell transplant from a male donor was found to have peripheral blood cells almost entirely replaced by donor cells carrying a male karyotype, while her non-blood cells remained female. This meant that NIPT read massive amounts of Y-chromosome DNA and returned a completely inaccurate fetal fraction estimate.14PubMed Central. Noninvasive prenatal screening in a pregnant woman with a history of stem cell transplant from a male donor: A case report and literature review Similar cases have been reported in other transplant recipients, where the Y chromosome from a male donor produced sex discrepancies on NIPT.15PubMed Central. Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report One especially complex case involved a woman who had both a bone marrow transplant and a donor-egg IVF pregnancy, meaning three distinct genomes were contributing DNA to her blood sample.16PubMed Central. cfDNA deconvolution via NIPT of a pregnant woman after bone marrow transplant and donor egg IVF
If you have a transplant history, you should tell your provider before NIPT is ordered. Some labs can adjust their analysis or recommend alternative methods for fetal sex determination, such as ultrasound alone.
Undetected Maternal Cancer
In very rare instances, an abnormal NIPT result is the first clue that the mother has an undiagnosed cancer. Tumors shed their own cell-free DNA into the bloodstream, and because tumor DNA typically contains many duplications and deletions across the genome, it can skew the ratios that NIPT uses to assign chromosome counts. The result may look like multiple aneuploidies, unusual monosomies, or a test failure that does not fit any expected fetal pattern.17PubMed Central. Current Controversies in Prenatal Diagnosis 2: NIPT Results Suggesting Maternal Cancer Should Always Be Disclosed While this does not typically produce a simple “wrong sex” call, it can create confusing results around sex chromosomes and raise alarm about conditions the fetus does not actually have. Providers who see a bizarre constellation of abnormalities on NIPT, especially multiple aneuploidies that would be incompatible with life, should consider the possibility of an occult maternal malignancy.
Twin and Higher-Order Pregnancies
Sex determination in twin pregnancies is inherently harder for NIPT because the lab has to distinguish whether detected Y-chromosome DNA is coming from one twin, both twins, or neither. When both twins are female, the absence of any Y signal makes the call straightforward, and studies report 100% sensitivity and specificity for that scenario. When at least one twin is male, accuracy drops slightly: one model using a two-step regression approach achieved about 98% sensitivity and 95% specificity for identifying a male twin in a pair.18PubMed Central. Fetal sex determination in twin pregnancies using non-invasive prenatal testing
For triplets, accuracy remains high but dips slightly further. One validation study found sex determination accuracy of about 99% in twins and roughly 98% in triplets.19PubMed. Validation of fetal DNA fraction estimation and its application in noninvasive prenatal testing for aneuploidy detection in multiple pregnancies The challenge in multiples is that fetal fraction is split among the fetuses, so each baby contributes less DNA individually. With fraternal twins of different sexes, the lab can detect Y-chromosome presence and determine that at least one is male, but pinpointing which twin is which sex requires either ultrasound or more sophisticated analytical models.
When Sex Chromosomes Do Not Match Anatomy
Sometimes NIPT and ultrasound disagree about fetal sex not because of a testing error but because the baby has a difference of sex development (DSD). These are conditions where the chromosomal sex and the visible anatomy develop along different paths. A study reviewing cases where NIPT sex results clashed with ultrasound findings found that about 36% of the discordances could be traced to a DSD. The most common category was 46,XY DSD, in which the baby has Y-chromosome DNA but develops female-appearing anatomy. Androgen insensitivity syndrome accounted for roughly a third of those XY DSD cases.20PubMed Central. Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography
In these situations, NIPT is technically reporting the chromosomal sex correctly, but the result conflicts with what appears on ultrasound. This can be alarming for parents who are not expecting it, and it often prompts further genetic workup. Providers experienced in prenatal genetics generally recommend discussing the possibility of DSD when there is a persistent disagreement between NIPT and imaging, rather than assuming one test is simply wrong.
Differences Between NIPT Methods
Not all NIPT platforms analyze DNA the same way. The main approaches include whole-genome sequencing, targeted sequencing, single-nucleotide polymorphism analysis, and microarray-based methods. For common trisomies, a systematic review found that these methods perform similarly in terms of sensitivity and specificity, though they differ in their positive predictive values, meaning some platforms are more likely than others to generate a false alarm.21PubMed Central. Systematic Review of Accuracy Differences in NIPT Methods for Common Aneuploidy Screening
For sex chromosome conditions specifically, the differences become more pronounced. A meta-analysis found that for detecting Turner syndrome (45,X), one widely used sequencing approach had a sensitivity of about 94%, while a targeted sequencing method came in lower at around 83%. Test failure rates also varied, from under 1% with one platform to nearly 6% with another.22PubMed Central. Non-invasive prenatal testing for the prenatal screening of sex chromosome aneuploidies: A systematic review and meta-analysis of diagnostic test accuracy studies These differences matter because a test failure is not the same as a normal result. If your NIPT comes back with no call for sex chromosomes, it could mean the fetal fraction was too low or the platform struggled with the sample, not that everything is fine.
Laboratory Handling and Contamination
Most discussion of NIPT errors focuses on biological causes, but the sample still has to make it through a lab. Sample contamination, mislabeling, and degradation during shipping are all possible. These are harder to study because labs do not routinely publish their internal error rates, but emerging technologies aim to reduce the problem. One research group developed a nanoparticle-based detection method that can identify male DNA in mixed samples without the amplification step used in standard processing, eliminating one source of contamination from the pipeline.23Analytical Chemistry. Nanoparticle-Enhanced Surface Plasmon Resonance Imaging Enables the Ultrasensitive Detection of Non-Amplified Cell-Free Fetal DNA for Non-Invasive Prenatal Testing Until such methods become standard, the conventional advice holds: if something about your result seems off, a redraw or confirmatory test is reasonable.
What to Do When NIPT Sex Does Not Match Ultrasound
A discrepancy between NIPT and ultrasound sex calls is more common than a clear wrong answer. NIPT might say male while the anatomy scan at 20 weeks shows female anatomy, or vice versa. Experts recommend that diagnostic fetal chromosome analysis, such as amniocentesis, be offered whenever NIPT returns an abnormal sex chromosome result, because NIPT remains a screening test rather than a diagnostic one.24PubMed. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous? The goal of follow-up testing is not just to settle the sex question but to determine whether there is an underlying chromosomal condition, a DSD, or simply a testing artifact that can be explained and moved past.
Providers sometimes hesitate to raise the possibility of error because NIPT is marketed as highly accurate, which it is. But “highly accurate” and “never wrong” are different things. If your NIPT sex result and your ultrasound do not match, it does not automatically mean anything is wrong with your baby. It means more information is needed.
Regulatory Differences Around the World
Access to fetal sex information from NIPT varies dramatically by country, and the regulations reflect different cultural anxieties about what families might do with that information. India and China have laws that prohibit revealing fetal sex during prenatal testing because of concerns about sex-selective termination. Germany allows the information to be disclosed only after 12 weeks of gestation. In other countries, sex reporting is a routine part of the NIPT result with no restrictions.25PubMed Central. Regulating non-invasive prenatal testing (NIPT) for fetal sex determination In places where sex determination is restricted, labs may still generate the data internally for quality-control purposes but withhold it from the report. This means the accuracy of sex determination in those settings is less well studied, since there is no systematic comparison against birth outcomes.
Even in countries where sex is reported freely, the question of what to do with an unexpected result is evolving. Genetic counselors increasingly recommend that families treat the NIPT sex call as a strong probability rather than a certainty, especially when the result was obtained early in pregnancy, when BMI is elevated, or when the pregnancy involves multiples. The gap between “screening test” and “diagnostic test” is small in percentage terms but large in the number of families affected when millions of tests are performed annually.